Genomics-Enabled Prevention

Jun 4, 2012, 01:00 AM by Michael Croft

Forbes | Ronald Davis, director of the Stanford Genome Technology Center, believes the time to invest in genomics and personalized medicine is now.

June 4, 2012 | Ronald Davis, director of the Stanford Genome Technology Center, believes the time to invest in genomics and personalized medicine is now. Even though genetic data alone hasn't proven completely predictive, genomics-enabled personalized medicine is on course for exciting breakthroughs, Davis says, with prevention being a prime target. Forbes